Advertisement
Canada markets close in 4 hours 35 minutes
  • S&P/TSX

    21,775.79
    -97.93 (-0.45%)
     
  • S&P 500

    5,008.30
    -63.33 (-1.25%)
     
  • DOW

    37,868.17
    -592.75 (-1.54%)
     
  • CAD/USD

    0.7299
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    82.28
    -0.53 (-0.64%)
     
  • Bitcoin CAD

    87,071.59
    -1,823.27 (-2.05%)
     
  • CMC Crypto 200

    1,372.07
    -10.50 (-0.76%)
     
  • GOLD FUTURES

    2,346.30
    +7.90 (+0.34%)
     
  • RUSSELL 2000

    1,967.63
    -27.79 (-1.39%)
     
  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     
  • NASDAQ

    15,441.57
    -271.18 (-1.73%)
     
  • VOLATILITY

    16.99
    +1.02 (+6.39%)
     
  • FTSE

    8,071.00
    +30.62 (+0.38%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     

Today's Research Reports on Trending Tickers: Ampio Pharmaceuticals and OPKO Health

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / U.S. equities closed up on Tuesday, as investors set aside trade related concerns and focus on strong corporate earnings. The Dow Jones Industrial Average increased 0.50 percent to close at 25,628.91, while the S&P 500 Index has gained 0.28 percent to close at 2,858.45. The Nasdaq Composite Index climbed 0.31 percent to close at 7,883.66.

Hussein Sayed, chief market strategist at FXTM said in a note “The strong earnings season has been the key factor lifting U.S. stocks,” he further added “However, as we get closer to the end of company announcements, the focus will return to trade frictions, geopolitics and the forthcoming U.S. midterm elections,”.

RDI Initiates Coverage on:

Ampio Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=AMPE

ADVERTISEMENT

OPKO Health, Inc.
https://rdinvesting.com/news/?ticker=OPK

Ampio Pharmaceuticals' stock moved 2.05% lower Tuesday, to close the day at $2.86. The stock recorded a trading volume of 3,004,930 shares, which was above its three months average volume of 886,495 shares. In the last year, Ampio Pharmaceuticals' shares have traded in a range of 0.38 - 4.95. The share price has gained 652.63% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.43 is below its 200-day moving average of $2.60. Shares of Ampio Pharmaceuticals have gained roughly 22.22 percent in the past month and are down 29.73 percent year-to-date.

Access RDI's Ampio Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AMPE

On Tuesday, shares of OPKO Health recorded a trading volume of 3,449,441 shares, which was below the three months average volume of 6,918,325 shares. The stock ended the day 2% higher at $5.62. The share price has fallen 22.38% from its 52 week high with a 52 week trading range of 2.66 - 7.24. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.32 is above its 200-day moving average of $4.13. Shares of OPKO Health have gained roughly 7.87 percent in the past month and are up 14.69 percent year-to-date.

Access RDI's OPKO Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OPK

Our Actionable Research on Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) and OPKO Health, Inc. (NASDAQ:OPK) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com